Related by context. Frequent words. (Click for all words.) 69 include ColorectAlert TM 69 Regulatory Disclosure 68 LungAlert TM 67 HOW LONG WAS 67 deCODE AF TM 67 广东 频道 67 Nasdaq RGDX 66 By HARVEY SIMPSON 66 Baxa customer 66 Through Glycoscience R 66 By Matt Arado 66 By Donny Henn 66 By Katy Burne 66 By QianMian #-#-# 66 http:/www.vical.com 66 By Corey Voegele 66 BY DANNY GALLAGHER 66 By KEVIN DING 65 By BEVERLY CORBELL 65 Sarah T. Szafranski 65 By JULIE FARREN 65 TSX VENTURE MOM 65 markets therapeutic ultrasonic 65 * Azixa 65 By Priyanka Dayal 65 By Jack Komperda 65 ParaBody fitness equipment 65 targeted immunotherapies 65 Harpo Studios produces 65 By Doris Yon 65 By Tona Kunz 65 By Kathryn Grondin 65 By DANIE HARRELSON 65 kits purified reagents 65 www.vicortech.com 65 By SEAN McCANN 65 By DAVE BUCHANAN 65 DONNER METALS LTD 65 By TERRANCE HARRIS 65 By CHRIS MARSHALL 65 By GlobeNewswire #/#/# 64 By KEVIN MINNICK 64 By RAD SALLEE 64 monitoring disposables endosurgery 64 By Jason Kaneshiro 64 By Miriam Reimer 64 By Lisa Eckelbecker 64 Note SHIPPING CHARGES 64 By MIKE AGOGLIATI 64 Inc. NASDAQ RRGB 64 By Julian Pecquet 64 By Amy Boerema 64 By NATHAN BRUTTELL 64 By DEREK BELT 64 By Joseph Woelfel 64 Visit Telescopes.com 64 Trailers Movie 64 By TraderMark 64 News Assignment Editors 64 Mes amis 64 including nutritionals devices 64 Liberia Mali Niger 64 contact@apctest.com 64 www.titanpharm.com 63 paraffin embedded specimens 63 By Steve Zalusky 63 oncolytic virus therapies 63 pragmatic reengineering 63 kpender@sfchronicle.com 63 cystic fibrosis inflammation autoimmune 63 By Laurie Kulikowski 63 www.anadyspharma.com 63 www.omrix.com 63 BY BALK 63 biomarker assay development 63 By MATT KATZ 63 By Neil Osterweil 63 By REBECCA BEITSCH 63 Joseph Levi Esq 63 multivalency toward drug 63 var path 63 orderonlineviagra 63 By Alex Kuffner 63 Nasdaq MNKD focuses 63 By LEO STRUPCZEWSKI 63 Two Upcoming Investor 63 III dtfoster@charlotteobserver.com 63 By BRIAN MCTAGGART 63 About Signature Devices 63 www.caliperLS.com 63 Staff Writer larry@gaffneyledger.com 63 www.syntapharma.com 63 approvals revisions mgmt 63 TRISCUIT crackers 63 REAs Rich Enterprise 63 By TOM LOUNSBERRY 63 TFN NEWS BRIEFING Macroeconomics 63 By Marty Maciaszek 63 commercializing anti infective 62 By BILL PLUNKETT 62 NASDAQ SNTA biopharmaceutical